Moreover, conflicting reports on SALL4 expression in CCA (3, 20, 21, 24, 25) raise the possibility that its role has been underappreciated because of diagnostic challenges and tumor heterogeneity. The gene discussed is SALL4; the disease is cholangiocarcinoma.